Connect with us

Technology

Alzheimer’s Drug Discovery Foundation’s Diagnostics Accelerator (DxA) invests $10M in Alamar Biosciences, Inc. to Advance Precision Medicine in Alzheimer’s Disease

Published

on

Largest DxA investment to date supports development of Alamar’s ARGO™ DX System and future in vitro diagnostic tests

NEW YORK and FREMONT, Calif., Jan. 8, 2025 /PRNewswire/ — The Alzheimer’s Drug Discovery Foundation (ADDF)‘s Diagnostics Accelerator (DxA) today announced a $10M investment in Alamar Biosciences, Inc. This landmark investment, the largest in DxA history, will expedite the translation of the ARGO-HT research platform into an FDA-cleared system to support the development of in vitro diagnostic (IVD) tests – the gold standard of diagnostics. Alamar’s ARGO HT System automates high-throughput NULISA™ assays, offering ultrasensitive protein detection and multiplexing for analyzing blood-based biomarkers related to Alzheimer’s and other dementias.

“In cancer and other diseases of aging, we have biomarker panels that allow clinicians to better differentiate from many underlying causes of the disease and more importantly, how to tailor treatments based on each patient’s individual biomarker profile,” said Howard Fillit, MD, Co-Founder and Chief Science Officer at the ADDF. “There is a pressing need to have biomarker panels for Alzheimer’s patients so we can better diagnose and develop new treatments. Alamar’s innovative platform provides the opportunity for a first of its kind blood panel in Alzheimer’s, which will be an important step as we move forward to delivering a more personalized approach for patients.”

“The powerful combination of ultra-high sensitivity and multiplexing unlocks the potential to measure novel biomarker signatures, enabling differential diagnosis in neurodegeneration,” said Niranjan Bose, Managing Director, Health and Life Sciences at Gates Ventures. “The investment in the development of ARGO DX focuses on translating this capability onto a scalable platform for widespread clinical use. We are excited to partner with the Alamar team to bring this vision to reality and advance the molecular diagnostics landscape in Alzheimer’s disease.”

The holy grail for Alzheimer’s diagnostics is to develop an accessible and scalable blood panel that can detect multiple biomarkers, providing clinicians with a better understanding of each patient’s individual disease biology. Alamar’s NULISA™ technology is unique in that it enables ultra-high sensitivity with the ability to test for multiple targets at once.

“Experts in the field have showcased the performance of the NULISA technology in detecting essentially all the important biomarkers in blood for Alzheimer’s and related dementias,” said Yuling Luo, Ph.D., Founder, Chairman, and CEO of Alamar Biosciences, Inc. “The ARGO DX platform can potentially revolutionize the biomarker space by allowing researchers to go from discovery to detection of biomarker panels that stratify patient subsets and disease factors that would otherwise have gone unnoticed.”

“A diagnostic platform such as Alamar’s, that can detect and measure multiple disease pathways, will be instrumental in paving the way for early detection, biology of aging-based differential diagnosis, allowing for a precision medicine approach in Alzheimer’s,” commented Dr. Fillit.

This recent investment in Alamar reflects the DxA’s larger vision to accelerate the development of new biomarkers and diagnostic tools to enable early detection and diagnosis of Alzheimer’s. To date, the DxA has invested more than $80 million in nearly 70 projects, underscoring its commitment to bringing accessible, affordable, and scalable diagnostics to patients struggling with Alzheimer’s disease. Along with blood tests, the DxA’s diverse portfolio includes retinal scans and digital tools that will not only provide patients with early and accurate diagnoses but also work in tandem and have the potential to be used for screening, prognostic, and prevention efforts. 

About The Alzheimer’s Drug Discovery Foundation (ADDF)
Founded in 1998 by Leonard A. and Ronald S. Lauder, the Alzheimer’s Drug Discovery Foundation is dedicated to rapidly accelerating the discovery of drugs to prevent, treat and cure Alzheimer’s disease. The ADDF is the only public charity solely focused on funding the development of drugs for Alzheimer’s, employing a venture philanthropy model to support research in academia and the biotech industry. The ADDF’s leadership and contributions to the field have played a pivotal role in bringing the first Alzheimer’s PET scan (Amyvid®) and blood test (PrecivityAD®) to market, as well as fueling the current robust and diverse drug pipeline. Through the generosity of its donors, the ADDF has awarded more than $360 million to fund over 760 Alzheimer’s drug discovery programs, biomarker programs and clinical trials in 21 countries. To learn more, please visit: http://www.alzdiscovery.org/.

ABOUT THE DIAGNOSTICS ACCELERATOR (DxA)
The Diagnostics Accelerator, created in July 2018, is a $100 million global research initiative from partners including ADDF Co-Founder Leonard A. Lauder, Bill Gates, Jeff Bezos, MacKenzie Scott, the Dolby family, the Charles and Helen Schwab Foundation, The Association for Frontotemporal Degeneration, among others, to develop novel biomarkers for the early detection of Alzheimer’s disease and related dementias.

This research initiative is dedicated to accelerating the development of affordable and accessible biomarkers to diagnose Alzheimer’s disease and related dementias and advance the clinical development of more targeted treatments. Through translational research awards and access to consulting support from industry experts, this program will challenge, assist and fund the research community in both academia and industry to develop novel peripheral and digital biomarkers.

About Alamar Biosciences, Inc.
Alamar Biosciences is a privately held life sciences company with a mission to power precision proteomics to enable the earliest detection of disease. The company’s proprietary NULISA Platform along with the ARGO™ HT System work seamlessly with the latest advances in genomics to achieve single digit attomolar detection sensitivity, greatly surpassing the most sensitive protein detection technology on the market today. For more information, please visit alamarbio.com.

View original content to download multimedia:https://www.prnewswire.com/news-releases/alzheimers-drug-discovery-foundations-diagnostics-accelerator-dxa-invests-10m-in-alamar-biosciences-inc-to-advance-precision-medicine-in-alzheimers-disease-302345929.html

SOURCE Alzheimer’s Drug Discovery Foundation

Continue Reading

Technology

Lubbock Plastic Surgeon Dr. Thanapoom Boonipat Leads Suturing Workshop for Texas Tech Women in STEM Premed Students

Published

on

By

Suturing workshop

LUBBOCK, Texas, Oct. 25, 2026 /PRNewswire/ — Dr. Thanapoom “Mo” Boonipat, plastic surgeon and founder of FacePlus Plastic Surgery Institute in Lubbock, led a hands-on suturing workshop and career Q&A session for premed students at Texas Tech University. The event was organized by Women in STEM at Texas Tech University.

During the workshop, students practiced suturing fundamentals on suture pads using surgical instruments, with Dr. Boonipat demonstrating technique and coaching students individually. The session also included an open discussion about the path to a career in medicine, including medical school, residency training, and choosing a surgical specialty.

“Every surgeon remembers the first time they held a needle driver. Giving premed students that experience early — along with honest answers about the road ahead — can make the path into medicine feel real and reachable. I was glad to spend the afternoon with such motivated students.” — Dr. Thanapoom Boonipat

“Organizations like Women in STEM do important work connecting young women with mentors and hands-on experience in fields where they are still underrepresented, including surgery. FacePlus is proud to support that effort here in our own community in Lubbock.” — Dr. Thanapoom Boonipat

Women in STEM is a Texas Tech University student organization that supports women pursuing undergraduate and graduate studies in science, technology, engineering and mathematics. Events like this connect students with practicing professionals and give them early, practical exposure to clinical skills.

Dr. Boonipat is a plastic and craniofacial surgeon. His training includes an integrated plastic surgery residency at Mayo Clinic and a craniofacial, maxillofacial, and facial aesthetics fellowship at Chang Gung Memorial Hospital in Taiwan, following medical school at Dartmouth and undergraduate study in biomedical engineering at Johns Hopkins. He founded FacePlus Plastic Surgery Institute in Lubbock in 2024.

About FacePlus Plastic Surgery Institute:
FacePlus Plastic Surgery Institute is a plastic surgery practice in Lubbock, Texas, founded by Thanapoom Boonipat, MD. The practice provides cosmetic and reconstructive plastic surgery, including facial, breast, and body procedures, serving patients in Lubbock and across West Texas. For more information, visit facepluspsi.com.

Media Contact:
FacePlus Plastic Surgery Institute
moboonipatmd@facepluspsi.com
(806) 503-2090
Lubbock, Texas

Press Release Service provided by 24-7PressRelease.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/lubbock-plastic-surgeon-dr-thanapoom-boonipat-leads-suturing-workshop-for-texas-tech-women-in-stem-premed-students-302918808.html

SOURCE FacePlus Plastic Surgery Institute

Continue Reading

Technology

Vantrue Announces Early Black Friday Sale with Up to 44% Off Select Dash Cams

Published

on

By

November 1–21, 2026 | Official Website: Vantrue.com

SHENZHEN, China, Oct. 25, 2026 /PRNewswire/ — Vantrue, a dash cam brand dedicated to helping drivers capture the road with confidence, is launching its three-week Black Friday campaign from November 1 to November 21, 2026. The event brings together discounts of up to 44% on selected dash cams, a 100% win-rate prize wheel for subscribers, and exclusive bidding events, giving drivers multiple ways to discover and save on Vantrue products.

Every Eligible Spin Wins a Prize

The Black Friday excitement starts with Vantrue’s 100% win-rate spin wheel. Visitors can subscribe through the official website and spin for a chance to receive exciting rewards, including the latest Vantrue dash cams, special prize bundles, and other surprises. Each subscriber is eligible for one spin during the campaign.

Black Friday Deals in Two Waves

Vantrue’s Black Friday offers will roll out in two waves, featuring discounts on selected dash cams for everyday drivers, rideshare professionals, and those looking to upgrade their in-car recording setup.

Wave 1: November 1–10, 2026

Vantrue E1 Lite: 36% off — $69.99 (regular price: $109.99)
 Vantrue N2X: 36% off — $159.99 (regular price: $249.99)
 Vantrue N4S: 44% off — $199.99 (regular price: $359.99)
 

Wave 2: November 11–21, 2026

Vantrue E1 Pro S: 35% off — $129.99 (regular price: $199.99)
 Vantrue N5S: 36% off — $293.99 (regular price: $459.99)
 Vantrue N4 Pro S: 40% off — $279.99 (regular price: $469.99)
 

Exclusive Bidding Events Add More Excitement

In addition to the promotional pricing, Vantrue will host two special bidding events, offering participants another way to pursue selected dash cams at competitive prices.

BID #1: November 5–7, 2026 — Bid on featured products for a chance to secure them at a lower price.BID #2: November 12–14, 2026 — Return for another opportunity to bid on premium models.

With multiple ways to participate throughout the three-week event, Vantrue’s Black Friday campaign combines savings, interactive rewards, and special shopping opportunities in one destination.

Join Vantrue’s Black Friday Event

From November 1 through November 21, 2026, drivers can explore the latest offers, take part in the prize wheel, and join the bidding events through Vantrue’s official website.

Visit https://www.vantrue.com/ for campaign details and product offers.

About Vantrue

Founded in 2015, Vantrue is a leading global dash cam brand dedicated to providing intelligent, reliable, and user-centric driving solutions. With a focus on innovative technology, dependable performance, and user-friendly design, Vantrue develops dash cams for everyday drivers, families, and professionals on the road. Committed to helping drivers capture every journey with greater confidence and peace of mind, Vantrue continues to innovate to make every drive safer and every moment worth capturing.

Media Contact
Vantrue Media Relations
Email: support@vantrue.net
Website: https://www.vantrue.com

View original content:https://www.prnewswire.com/news-releases/vantrue-announces-early-black-friday-sale-with-up-to-44-off-select-dash-cams-302918196.html

SOURCE Vantrue

Continue Reading

Technology

LexisNexis Coplogic Solutions Introduces Field Clarity for LexisNexis® Desk Officer Reporting System (DORS) at IACP 2026

Published

on

By

A new, modern DORS and Field Clarity, the First AI-Guided Smartphone Video Assistant, Enhances Community Experience and Helps Improve Evidence, Case Building

ORLANDO, Fla., Oct. 25, 2026 /PRNewswire/ — LexisNexis® Coplogic™ Solutions today announced its modernized LexisNexis® Desk Officer Reporting System (DORS) community online reporting solution and the addition of DORS with Field Clarity, an AI-guided video assistant designed to improve field documentation accuracy and enable faster resolution by law enforcement agencies (LEAs). Field Clarity is designed to help community members submit reports to their local LEAs using DORS via intuitive step-by-step instructions. A hands-on experience for DORS with Field Clarity will be available for demonstration during the 2026 International Association of Chiefs of Police (IACP) annual conference.

“Agencies generally look to strategic partners like us not just for technology, but also for relief, reinforcement, and credibility across three tightly connected challenges: public expectation, workforce strain and digital evidence overload,” said Jason LaRue, associate vice president, LexisNexis Coplogic Solutions. “Our modernized LexisNexis Desk Officer Reporting System (DORS) helps agencies improve officer safety along with community member experiences. Field Clarity strengthens video evidence quality and digital evidence management to reduce friction and alleviate strain on a challenged workforce.”

Key Highlights
Integrated into LexisNexis® Desk Officer Reporting System (DORS), Field Clarity is the first AI-Guided video assistant for community member online reporting that:

Transforms data capture from passive intake into intelligent, guided capture to help create more positive officer and civilian mobile-first experiencesDrives more accurate field documentation, evidence and case building to help with faster resolution and enhanced public safetyBenefits civilians submitting reports with intuitive, step-by-step instructions, almost like having a digital assistant with them in real timeBenefits officers by bringing video, photos and scanned data together for a clearer picture of an event without the need to track down additional details

How the DORS with Field Clarity Solution Works
DORS allows each law enforcement agency to collect information directly from civilians on more than 200 incident types based on the needs of their community. DORS and Field Clarity make the filing of an online report experience easier by guiding users intuitively through each step of the process on their smartphone device, similar to having a personal digital assistant. Instead of asking a driver, for example, to fill out forms and guess what’s needed, the Field Clarity conversational interface prompts them to scan their driver’s license, capture a VIN or record a short walkaround video explaining what happened during the incident, all while capturing the data necessary to complete the report.

For civilians, being able to easily film on-scene evidence means less confusion and need for reentries or follow-up by the sworn officer responsible for approving reports. For officers, the benefits include cleaner, more complete accident reports and less time spent requesting and gathering additional details. With reports fed directly into the agency’s Record Management System (RMS), law enforcement also benefits from more efficient workflows and stronger documented cases for their investigators. DORS is used by nearly 600 agencies in North America, saving agencies approximately 900,000 personnel hours and $90 million annually*

“Trust in law enforcement is built one interaction at a time. Every opportunity for a community member to engage with their police department matters, including something as routine as filing a report,” said Sarah E. Connolly, co-founder of Guardian Communications, FBI-LEEDA instructor and retired Baltimore Police lieutenant and PIO. “When technology makes that process easier, improves the quality of information collected and supports a more responsive agency, it has the potential to do more than improve efficiency. It can help strengthen the relationship between law enforcement and the communities they serve.”

LexisNexis Coplogic Solutions delivers solutions and capabilities that can create a clearer line of sight from the field to law enforcement leadership, strengthening the connection between daily operations, workforce support, data management and community trust. DORS with Field Clarity is available through LexisNexis® Command Center, a single access point to the LexisNexis Coplogic Solutions data and analytics solutions suite, including LexisNexis®  BuyCrash®, LexisNexis® eCrash and LexisNexis® eCitation solutions. Coplogic Solutions also offers Unified Performance Dashboards for crash and citation mapping and illustrated visualizations, which connect field data with contextual insight in a single, coherent view – so law enforcement leaders can better understand and more confidently explain to their communities not just what is happening in near-real time, but also why. 

To speak with Coplogic law enforcement experts about LexisNexis Desk Officer Reporting System (DORS) with Field Clarity and experience the solution firsthand, visit LexisNexis Coplogic Solutions at IACP Booth #941, October 24 – 27, 2026 in Orlando, Florida. To learn more, check out this video: LexisNexis® Desk Officer Reporting System (DORS).

About LexisNexis Risk Solutions
LexisNexis® Risk Solutions provides customers with information-based analytics and decision tools that combine public and industry-specific content with advanced technology and algorithms to assist them in evaluating and predicting risk and enhancing operational efficiency. Headquartered in metro Atlanta, Georgia, the company has offices throughout the world, serves customers in more than 190 countries and territories and is part of RELX. For more information, please visit LexisNexis Risk Solutions.

About LexisNexis Coplogic Solutions
LexisNexis® Coplogic™ Solutions is committed to meeting law enforcement agencies where they are on the road to saving more lives and helping take them where they want to be by delivering an innovative full suite of data sophistication solutions to create workflow efficiencies while delivering world-class crash and citation data and analytics visualizations through advanced technology. Our proven solutions, developed by and specifically for law enforcement, can help agencies operate more effectively, increase services to their communities and improve traffic and overall public safety through electronic, mobile-first authoring capabilities, web-based eCommerce solutions, analytics and more. For more information, please visit risk.lexisnexis.com/Coplogic.

Media Contacts: 
Chaz Abbott
LexisNexis Risk Solutions
chaz.abbott@lexisnexisrisk.com
+1 949.922.1167

*Based on a 2025 LexisNexis Coplogic Solutions internal study

View original content to download multimedia:https://www.prnewswire.com/news-releases/lexisnexis-coplogic-solutions-introduces-field-clarity-for-lexisnexis-desk-officer-reporting-system-dors-at-iacp-2026-302918694.html

SOURCE LexisNexis Risk Solutions

Continue Reading

Trending